11 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $2.5B | $451M | 0.0% | 21.1% | $682M | — | $497M |
| 2024 | $2.1B | $404M | 0.0% | 21.2% | $572M | — | $669M |
| 2023 | $1.9B | $283M | 0.0% | 17.9% | $397M | — | $245M |
| 2022 | $1.5B | $245M | 0.0% | 19.1% | $351M | — | $28M |
| 2021 | $1.1B | $182M | 0.0% | 17.4% | $235M | — | $461M |
| 2020 | $926M | $145M | 0.0% | 18.0% | $227M | — | $278M |
| 2019 | $861M | $100M | 0.0% | 14.8% | $184M | $0 | $132M |
| 2018 | $705M | $73M | 0.0% | 14.3% | $141M | $80M | $23M |
| 2017 | $436M | $39M | 0.0% | 14.9% | $86M | $222M | $26M |
| 2016 | $422M | $13M | 0.0% | 12.5% | $78M | $165M | $37M |
| 2015 | — | -$9M | — | — | — | $378M | $15M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $707M | $124M | 0.0% | 20.0% | $145M | — | $653M |
| Dec '25 | $708M | $135M | 0.0% | 21.6% | $188M | — | $497M |
| Sep '25 | $660M | $111M | 0.0% | 21.5% | $235M | — | $285M |
| Jun '25 | $603M | $90M | 0.0% | 20.9% | $142M | — | $46M |
| Mar '25 | $559M | $115M | 0.0% | 20.3% | $116M | — | $441M |
| Dec '24 | $537M | $117M | 0.0% | 23.4% | $183M | — | $669M |
| Sep '24 | $533M | $96M | 0.0% | 21.1% | $139M | — | $657M |
| Jun '24 | $528M | $88M | 0.0% | 19.9% | $104M | — | $511M |
| Mar '24 | $511M | $103M | 0.0% | 20.4% | $147M | — | $407M |
| Dec '23 | $498M | $78M | 0.0% | 17.5% | $146M | — | $245M |
| Sep '23 | $492M | $71M | 0.0% | 17.2% | $106M | — | $95M |
| Jun '23 | $461M | $61M | 0.0% | 17.0% | $74M | — | $39M |
| Mar '23 | $434M | $73M | 0.0% | 19.9% | $71M | — | $47M |
| Dec '22 | $394M | $69M | 0.0% | 19.4% | $127M | — | $28M |
| Sep '22 | $384M | $66M | 0.0% | 20.3% | $101M | — | $31M |
| Jun '22 | $351M | $49M | 0.0% | 17.2% | $85M | — | $43M |
| Mar '22 | $331M | $61M | 0.0% | 19.4% | $37M | — | $83M |
| Dec '21 | $309M | $50M | 0.0% | 17.8% | $62M | — | $461M |
| Sep '21 | $296M | $49M | 0.0% | 18.2% | $66M | — | $398M |
| Jun '21 | $278M | $40M | 0.0% | 15.3% | $57M | — | $339M |
How the market has priced MEDP against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Medpace Holdings, Inc.'s revenue has grown 22.3% per year, and net income grown 25.4% per year. These are computed facts, not advice.
As of FY2025, Medpace Holdings, Inc. reported — of total debt against $497M of cash.
In FY2025, gross margin was —, operating margin 21.1%, and net margin 17.8%.
As of Jun '26, Medpace Holdings, Inc. traded at a price-to-earnings ratio of about 32.9× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.